Document is current
Any future updates will be listed below
-
Authors
Yaguchi, Katsuki
Kunisaki, Reiko https://orcid.org/0000-0003-3083-9600
Sato, Sho
Haruyama, Serina
Kurimura, Kazuki
Nakamori, Yoshinori
Nishio, Masafumi
Toritani, Kenichiro
Wu, Rongrong
Kimura, Hideaki
Ebina, Toshiaki
Numata, Kazushi
Maeda, Shin
- License Information
-
More Information
Article History
Received: 20 June 2025
Accepted: 16 December 2025
First Online: 6 January 2026
Declarations
:
: K.Y.: speaker’s fee from AbbVie, EA Pharma, Janssen Pharmaceutical, Kissei outside the submitted work. R.K.: research grant and speaker’s and/or consultancy fees from AbbVie, EA Pharma, Eli Lilly, Kissei, Kyorin, Nippon Kayaku, Mitsubishi Tanabe, Takeda, Zeria, Janssen, and Pfizer, outside the submitted work. H.K.: research grant and speaker’s and/or consultancy fees from AbbVie, Astellas, EA Pharma, Janssen, Kissei, Kyorin, Kyowa Hakko Kirin, Mitsubishi Tanabe Pharma, Takeda, Zeria, and MOCHIDA, outside the submitted work. All other authors declare no competing interests.
: The authors would like to thank Analisa Avila, MPH, ELS, of Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.
